Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88)

Clinical Cancer Research

Volumn 19, Issue 8, 2013, Pages 2004-2013

  Nitta, Hidetoshi ^a   Wada, Yoshihiro ^a   Kawano, Yoshiaki ^a   Murakami, Yoji ^a   Irie, Atsushi ^a   Taniguchi, Keisuke ^c   Kikuchi, Ken ^b   Yamada, Gen ^d   Suzuki, Kentaro ^d   Honda, Jiro ^a   Wilson Morifuji, Masayo ^a   Araki, Norie ^a   Eto, Masatoshi ^a   Baba, Hideo ^a   Imamura, Takahisa ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^c YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^d WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL; CELL ASSAY; CELL MIGRATION; CELL MOTILITY; CELL STIMULATION; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; ENZYME RELEASE; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR INVASION;

ANILINE COMPOUNDS; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; COMPLEMENT C5A; CYTOSKELETON; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, CONFOCAL; NEOPLASM INVASIVENESS; NEOPLASMS; RECEPTOR, ANAPHYLATOXIN C5A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRAHYDRONAPHTHALENES; TIME-LAPSE IMAGING; TRANSPLANTATION, HETEROLOGOUS;

EID: 84877097920     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-1204     Document Type: Article

References (42)

1. Carroll MC. The complement system in regulation of adaptive immunity. Nat Immunol 2004;5:981-6. (Pubitemid 41057714)
2. Markiewski MM, DeAngelis RA, Benencia F, Ricklin-Lichtsteiner SK, Koutoulaki A, Gerard C, et al. Modulation of the antitumor immune response by complement. Nat Immunol 2008;9:1225-35.
3. Niculescu F, Rus HG, Retegan M, Vlaicu R. Persistent complement activation on tumor cells in breast cancer. Am J Pathol 1992;140:1039-43.
4. Müller-Eberhard HJ. Molecular organization and function of the complement system. Annu Rev Biochem 1988;57:321-47.
5. Morgan J, Spendlove I, Durrant L. The role of CD55 in protecting the tumour environment from complement attack. Tissue Antigens 2002;60:213-23. (Pubitemid 35398824)
6. Gancz D, Fishelson Z. Cancer resistance to complement-dependent cytotoxicity (CDC): problem-oriented research and development. Mol Immunol 2009;46:2794-800.
7. Liu J, Miwa T, Hilliard B, Chen Y, Lambris J, Wells A, et al. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J Exp Med 2005:201:567-77. (Pubitemid 40289547)
8. Mikesch JH, Buerger H, Simon R, Brandt B. Decay accelerating factor (CD55): a versatile acting molecule in human malignancies. Biochim Biophys Acta 2006;1766:42-52.
9. Guo RF, Ward PA. Role of C5a in inflammatory responses. Annu Rev Immunol 2005;23:821-52. (Pubitemid 40563186)
10. Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 2007;171:715-27. (Pubitemid 47440971)
11. DiScipio RG, Smith CA, Müller-Eberhard HJ, Hugli TE. The activation of human complement component C5 by a fluid phase C5 convertase. J Biol Chem 1983;258:10629-36. (Pubitemid 14244323)
12. Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006;6:682-7. (Pubitemid 43865238)
13. Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol 2009;27:4834-8.
14. Huber-Lang M, Youkin EM, Sarma JV, Riedermann N, McGuire SR, Lu KT, et al. Generation of C5a by phagocytic cells. Am J Pathol 2002;161:1849-59. (Pubitemid 35265542)
15. Gerard NP, Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature 1991;349:614-7. (Pubitemid 21912116)
16. Zwirner J, Fayyazi A, Götze O. Expression of the anaphylatoxin C5a receptor in non-myeloid cells. Mol Immunol 1999;36:877-84. (Pubitemid 30100840)
17. Buchner RR, Hugli TE, Ember JA, Morgan EL. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin. J Immunol 1995;155:308-15.
18. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7. (Pubitemid 36019639)
19. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004;4:540-50. (Pubitemid 38868623)
20. Retz MM, Sidhu SS, Blaveri E, Kerr SC, Dolganov GM, Lehmann J, et al. CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells. Int J Cancer 2005;114:182-9. (Pubitemid 40194284)
21. Lian Z, Yoon Y, Votaw J, Goodman MM, William L, Shim H. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 2005;65:967-71. (Pubitemid 40216458)
22. Saur D, Seidler B, Schneider G, Algül H, Beck R, Senekowitsch-Schmidtke R, et al. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology 2005;129:1237-50. (Pubitemid 41446863)
23. Markiewski MM, Lambris JD. Unwelcome complement. Cancer Res 2009;69:6367-70.
24. Schraufstatter IU, Trieu K, Sikora L, Sriramarao P, DiScipio R. Complement C3a and C5a induce different signal transduction cascades in endothelial cells. J Immunol 2002:169;2102-10. (Pubitemid 34857676)
25. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronso SA, Kozlowski JM, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239-45. (Pubitemid 17082655)
26. Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, et al. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariae and multivariate analysis. Hepatogastroenterology 2002;49:311-6. (Pubitemid 34606541)
27. Banks PN, Barker MD, Burton DR. Recruitment of actin to the cytoskeletons of human monocyte-like cells activated by complement fragment C5a. Is protein kinase C involved? Biochem J 1988;252:765-9.
28. Monk PM, Banks P. Evidence for the involvement of multiple signaling pathways in C5a-induced actin polymerization and nucleation in human monocyte-like cells. J Mol Endocrinol 1991;6:241-7.
29. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Dev Biol 1993;9:541-73.
30. Singh S, Singh UP, Grizzle WE, Lillard JW Jr. CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest 2004;84:1666-76. (Pubitemid 39600573)
31. Takafuji S, Ishida A, Miyakuni Y, Nakagawa T. Matrix metalloproteinase-9 release from human leukocytes. J Investig Allergol Clin Immunol 2003;13:50-5. (Pubitemid 36781523)
32. Nabha SM, dos Santos EB, Yamamoto HA, Belizi A, Dong Z, Meng H, et al. Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12-dependent manner. Int J Cancer 2008;122:2482-90. (Pubitemid 351590480)
33. Miyata Y, Iwata T, Maruta S, Kanda S, Nishikido M, Kaga S, et al. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role. Eur Urol 2007;52:791-7. (Pubitemid 47126131)
34. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010;141:52-67.
35. Romualdez AG Jr, Ward PA. A unique complement derived chemotactic factor for tumor cells. Proc Natl Acad Sci U S A 1975;72:4128-32.
36. Orr W, Phan SH, Varani J, Ward PA, Kreutzer DL, Webster RO, et al. Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5. Proc Natl Acad Sci U S A 1979;76:1986-9. (Pubitemid 9172972)
37. Schiefeldecker HL, Schlaf G, Koleva M, Götze O, Jungermann K. Induction of functional anaphylatoxin C5a receptors on hepatocytes by in vivo treatment of rats with IL-6. J Immunol 2000;164:5453-8. (Pubitemid 30305229)
38. Takeyama H, Wakamiya N, O'Hara C, Arthur K, Niloff J, Kufe D, et al. Tumor necrosis factor expression by human ovarian carcinoma in vivo. Cancer Res 1991;51:4476-80.
39. Maeda H, Fang J, Inutsuka T, Kitamoto Y. Vascular permeability enhancement in solid tumors: various factors, mechanisms involved and its implications. Int Immunopharmacol 2003;3:319-28. (Pubitemid 36293960)
40. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998;279:509-14. (Pubitemid 28067271)
41. Nobes CD, Hall A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995;81:53-62.
42. Li Z, Hannigan M, Mo Z, Liu B, Lu W, Wu Y, et al. Directional sensing requires Gβγ-mediated PAK1 and PIXα-dependent activation of Cdc42. Cell 2003;114:215-27. (Pubitemid 36936915)